articleNature BiotechnologyJan 1, 2007Closed access

Structure-based maximal affinity model predicts small-molecule druggability

ACAlan C. ChengRGRyan G. ColemanKTKathleen T SmythQCQing CaoPSPatricia Soulard

Amgen (United States) · Pfizer (United States)

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

689
total citations
FWCI
32.91
Percentile
100%
References
31
Citations per year

Authors

8

Topics & keywords

Topics
Keywords
  • Druggability
  • Drug discovery
  • Small molecule
  • Computational biology
  • Drug target
  • Drug
  • Computer science
  • Chemistry
No related works found for this paper.

Funding